Tupper Colleen
EVP & Chief Financial Officer
Tupper Colleen has filed 2 SEC Form 4 filings (6 transaction rows) across 1 company, with disclosures dating back to 2025. 2 of those filings fall inside the rolling window. Most recent filing: Feb 12, 2026.
On the most recent filing, Tupper Colleen is listed as EVP & Chief Financial Officer at COLLEGIUM PHARMACEUTICAL, INC. Inside the rolling window, Tupper Colleen reported no open-market purchases and 1 open-market sale totaling $1.2M in COLL.
Companies traded
Other insiders at COLL
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$1.2M
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Tupper Colleen made?
Tupper Colleen has filed 2 SEC Form 4 filings (6 transaction rows) across 1 company since 2025.
Which companies does Tupper Colleen trade?
Tupper Colleen has filed SEC Form 4 disclosures for 1 company, including COLL.
When was Tupper Colleen's most recent SEC Form 4 filing?
Tupper Colleen's most recent SEC Form 4 filing on Tracefour is dated Feb 12, 2026.
What is Tupper Colleen's job title?
On the most recent SEC Form 4 filings tracked by Tracefour, Tupper Colleen is listed as EVP & Chief Financial Officer.
What is Tupper Colleen's total buy and sell value in the current window?
Inside the rolling retention window, Tupper Colleen bought $0 and sold $1.2M based on SEC Form 4 filings.
What was Tupper Colleen's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 30,000 COLL shares on 2025-11-06, worth $1.2M, per SEC Form 4 filings.